Oragenics, Inc. (ORNI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on February 2, 2009, covering events occurring on that date. The company, incorporated in Florida, operates in the biotechnology sector with a focus on probiotic technologies.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a specific corporate event rather than periodic financial performance.
Material Changes and Events
Under Item 8.01 (Other Events), the company announced an agreement with Garden of Life. This agreement grants Garden of Life exclusive rights to use Oragenics' ProBiora3 technology within the natural products market. The announcement was made via a press release dated February 4, 2009.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, management commentary on future outlook, or a discussion of risks and contingencies beyond the description of the new licensing agreement.
Key Facts for Investor Verification
- Verify the terms of the exclusive licensing agreement with Garden of Life regarding ProBiora3.
- Confirm the financial impact of this agreement on future revenue streams.
- Review the attached press release (Exhibit 99.1) for specific details on the market scope and duration of the exclusivity.